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Autosomal recessive Alport syndrome: immunohistochemical study of
type IV collagen chain distribution. Alport syndrome (AS) is an hereditary
disease of basement membrane collagen. It is mainly transmitted as a
dominant X-Iinked trait and caused by mutations in the COL4A5 gene
encoding the n5 chain of type IV collagen. However, autosomal recessive
AS due to mutations in the COL4A3 or COL4A4 genes could represent
up to 15% of AS. Using the immunofluorescence technique, we analyzed
the distribution of the different chains of type IV collagen in renal (12
specimens) and skin (4 specimens) basement membranes of 12 AS
patients belonging to 11 unrelated kindreds in which autosomal recessive
inheritance had been demonstrated (3 kindreds) or was suggested by
clinical and genealogic data (8 kindreds). The renal and skin distribution
was normal in one patient with COL4A4 mutation. A peculiar pattern of
distribution of the a3-a5(IV) chains was observed in the other patients. It
was characterized the co-absence of the cs3(IV), a4(IV) and a5(IV) chains
in the glomerular basement membrane, and the presence of the a5(IV)
chain in a series of extraglomerutar basement membranes including
capsular, collecting ducts and epidermal basement membranes, a combi-
nation never observed in X-linked AS. This immunohistochemical pattern
is correlated with the specific distribution of the n3-a5 chains of type IV
collagen chains within extraglomerular basement membranes. It could be
a useful marker for the identification of autosomal recessive AS.
Alport syndrome (AS) is an inherited disorder of glomerular
basement membrane (GBM) characterized by hematuria, pro-
gressive renal failure and sensorineural hearing loss, frequently
associated with ocular abnormalities such as lenticonus and
retinal anomalies [1—3]. The disease generally appears to be
inherited as an X-linked dominant trait [2, 4, 5]and the AS locus
has been mapped to the Xq22 region by linkage analysis [6]. The
COL4A5 gene encoding the basement membrane specific type IV
collagen a5 chain has also been mapped to Xq22 [7] and more
than 60 COL4A5 mutations have now been reported in AS
patients [8—10].
In a small percent of kindreds, autosomal recessive transmis-
sion has been suggested on the finding of parental consanguinity,
the absence of severe symptoms in parents and the severity of the
disease in females [4, 11, 12]. However, the existence of the
recessive mode of transmission of typical AS has long been
misappreciated. Two autosomal type IV collagen genes, COL4A3
and COL4A4, specifically expressed within the GBM and the
specialized ocular and inner ear basement membranes (BM) and
located head to head on chromosome 2q35-q37 have recently
been isolated [13, 14]. They were good candidate genes for
autosomal recessive AS. Using linkage analysis, we recently
confirmed this hypothesis in three consanguineous families by
demonstrating linkage to COL4A3-COL4A4 in the three kindreds
[12]. Moreover, mutations in COL4A3 or COL4A4 have been
identified in several cases of recessive AS [15]. These findings
provide clear evidence of the actual existence of the recessive
form of Alport syndrome.
The specific immunohistochemical distribution of type IV col-
lagen al-a4 chains and of the Alport antigen now identified as the
cs5 chain of type IV collagen [16] has been previously described in
normal kidneys. The classical al and a2 chains are distributed to
all tubular and vascular BM and, within the glomerulus, are
restricted to the mesangial matrix and the subendothelial aspect
of the GBM [17—20]. In contrast, the a3-a5 chains, which have a
selective GBM and distal tubular basement membrane (TBM)
localization, are present within the entire thickness of the GBM
[17—21]. Abnormal IHC distribution of the a3-a5 chains within
the GBM has been observed in most AS families: the three chains
are absent in males and have a discontinuous distribution in
females [4, 21—24]. We observed these anomalies in X-linked AS
patients with proven COL4A5 deletions, showing that a defect in
the COL4A5 gene impairs not only the normal expression of the
corresponding chain within the GBM, but also the normal incor-
poration of the a3-a4 chains within the GBM collageneous
network [10]. In addition, it has also been shown that the a5(IV)
chain which is normally distributed with the al(IV) and the
a2(IV) chains within the epidermal basement membrane (EBM)
is usually defective in the EBM of X-linked AS male patients, the
females exhibiting a segmental distribution of the antigen [22, 23].
The question of immunohistochemical changes associated with
defects in the COL4A3-COL4A4 genes remains open. The aim of
the present report is to describe the peculiar pattern of distribu-
tion of the a3-cs5 chains of type IV collagen in renal and
epidermal basement membranes of autosomal recessive AS pa-
tients.
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Methods
Patients and tissue
Immunohistochemical studies of kidney specimens were per-
formed in 12 patients (5 males and 7 females) belonging to 11
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a3-a4(IV) + + (S) + + — —
a5(IV) + ++ + ++ ++
Patients 2—12
a3-a4(IV) — — — — —
a5(IV) — ++ — ++ ++
unrelated families (Table 1). Four families were from Algeria
(families 1, 2, 4, and 6), one from Portugal (family 5), one from
Belgium (family 3), one from Colombia (family 8), one from
Morocco (family 11) and the others from France (families 7, 9 and
10). Immunohistochemical study was performed at the time of
diagnostic renal biopsy in seven patients and at the time of
nephrectomy before transplantation in five. In four of the five
nephrectomized patients, a renal biopsy allowing ultrastructural
study of the GBM had been previously performed. Immunohis-
tochemical study of skin biopsy specimens was also performed in
one male (family 7) and 3 female (families 1, 5 and 9) patients.
Four patients (kindreds 1 to 3) had proven autosomal recessive
AS. Patients belonging to kindreds 2 and 3 had classical AS
characterized by progressive hematuric nephritis, deafness, and
ocular changes in family 2. In kindred 1, no extra-renal changes
were observed. Ultrastructural alterations of the GBM were
observed in all three kindreds. They consisted of irregular,
alternating thick and thin GBM segments in kindreds 2 and 3 and
of extensive thinning of the GBM with occasional thick segments
in family 1. All patients were affected with the juvenile type of the
disease and developed ESRF between 11 and 16 years of age. The
mode of inheritance was established as autosomal recessive in the
three kindreds by exclusion of linkage to COL4A5 and compatible
linkage to COL4A3 in families 1 and 2 [12], identification of a
mutation in the COL4A4 gene in family 1 [15] and identification
of a mutation on the COL4A3 gene in family 3 [15].
Eight patients (kindreds 4 to 11) were also affected with AS.
They presented with hematuric nephritis which was familial in
three kindreds: hematuric nephritis in siblings in kindred 4 and
intermittent hematuria in the mother of the proband in kindreds
7 and 9. Renal involvement was associated with hearing loss (5
kindreds), ocular changes (3 kindreds) and ultrastructural and
immunohistochemical changes of the GBM (all kindreds). In two
kindreds (kindreds 5 and 10), the disease was of the juvenile type
with ESRF occurring at 14 and 26 years of age, respectively. In
five additional patients (families 4, 6, 8, 9 and 11), the disease was
also considered of the juvenile type on the finding of nephrotic
syndrome at 7 to 20 years of age, associated with moderate renal
insufficiency in one case. In family 7 the disease could not be
classified due to the young age of the patient. The mode of
transmission of the disease was not definitively established in
these eight families. However, it is compatible with an autosomal
recessive inheritance on the following criteria: (1) parental con-
sanguinity (kindreds 4 and 6); (2) severity of the disease in the
females (kindreds 4, 5, 8, 9 and 11); (3) absence of severe renal
disease of the AS type in ancestry.
Eight normal kidneys not used for transplantation, and 45 renal
biopsy specimens of patients presenting various types of acquired
glomerulopathies were tested as controls. Eight skin biopsy spec-
imens obtained from patients not affected with Alport syndrome
were used as controls.
Immunohistochemical procedures
Antibodies. Commercially available affinity-purified antibodies
made to pepsin-digested human placenta type IV collagen were
from Pasteur-Lyon. They recognize the collagenous domain of
[al(IV)2 a2(IV)] collagen. Monoclonal antibodies recognizing
the NC1 domain of respectively the al (MAB1) and the a3
(MAB3) chains of type IV collagen were from Wieslab (Lund,
Sweden). Monoclonal antibodies against the NC1 domain of the
a4 (Mab 85) and aS (Mab A7) chains of type IV collagen were
produced by one of us and their specificity has been demonstrated
[16, 20, 24].
Affinity-purified fluorescein isothiocyanate-conjugated sheep
IgG F(ab')2 fragment anti-rabbit and anti-mouse immunoglobu-
lins were from Silenius (Victoria, Australia).
Indirect immunofluorescence. Renal and skin samples were


















1 BS F + J 14 — — + + + COL4A4
2 AM M + J 15 + +(M+L) + +AA M + J 16 + +(M) nd
3 DC F + J 11 + nd + COL4A3
4 BE F + J — + nd +
5 LM F nd J 14 + + (M) + +
6 BM M + J — + nd +
7 CL M — nd — — nd + +
8 PL F nd J — + +(M) +
9 FP F — J — — +(M) + +
10 CB M — J 26 + nd +
11 HR F nd J — — nd +
Patients BE, BM, FP and HR have a ncphrotic syndrome at respectively 13, 20, 15 and 7 years of age. Patient PL has a nephrotic syndrome with
moderate renal insufficiency at 18 years. Patient CL has persistent proteinuria at 11 years of age. Abbreviations are: M, macular lesions; L, lenticonus;
nd, not determined.
Table 2. Relative distribution of the a3-a4(IV) chains and of the
a5(IV) chain in renal and epidermal basement membranes in controls
and Alport syndrome (AS) patient 1, and in AS patients 2 to 12
"Bowman's capsule labeling is very segmental (S) with anti-a3-a4(IV)
antibodies and more diffuse with anti-a5(IV) antibody
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Fig. 1. Immunofluorescence staining for collagen IT/chains in control renal (A-c) and skin (D, E) BM. al(IV) is strongly expressed in the mesangial matrix
and in capsular and tubular BM (A). a3(IV) and a5(IV) are codistributed within the GBM (B-C); the capsular BM is labeled with the anti-cs5(IV)
antibody (C). In the skin, all BM are labeled with the anti-csl(IV) antibody (D) whereas the distribution of the cs5(IV) chain is restricted to the epidermal
BM (E). Round spots seen on B, D and E are p-phenylene diamine stained nuclei.
laboratories mc, Naperville, IL, USA). Three micrometer cryo-
state serial sections were air dried and fixed in acetone for 10
minutes. After washing in fresh buffer (0.01 M PBS, pH 7.4), they
were incubated in a moist chamber with the appropriate dilution
of primary antibodies. Incubation with FITC secondary antibodies
was then done. Before incubation with Mab 85 and Mab A7, the
slides were pretreated with 0.1 M glycine, 6 M urea, pH 3.5 for 10
minutes, then rinsed with distilled water and processed for the
immunolabeling as described above. A mounting media contain-
ing p-phenylene-diamine was used to delay fluorescence quench-
ing and, in some cases, to visualize cell nuclei and tissue structure.
Labeling was examined with a Leitz Orthoplan microscope
equipped with appropriate filters. Tissue sections directly incu-
bated with secondary antibodies served as control experiments,
and negative results were obtained in all cases.
Results
Controls
Renal tissue. The al-a2 chains of type IV collagen were
distributed within all renal BM. In normal glomeruli, strong
mesangial labeling and faint staining of the subendothelial aspect
of the GBM were observed (Fig. 1A). The a3-cs4(IV) chains had
a restricted distribution within the GBM and the distal tubular
BM (Fig. 1B). Occasional focal labeling of the Bowman's capsule
BM could also be observed. The a5(IV) chain was codistributed
with the a3-a4(IV) chains within the GBM. It was also seen in
most Bowman's capsule BM, with a focal or peripheral distribu-
tion, and in distal tubular BM (Fig. 1C). Contrary to the a3-
a4(IV) chains, it was also detected in the BM of collecting ducts.
Decrease or complete effacement of al-a2(IV) labeling and
persistence of a strong linear a3-cs4-a5(IV) labeling of the GBM
were observed in sclerotic glomeruli (data not shown).
Skin specimens. In the skin, the al-a2 chains of type IV collagen
were distributed within all BM (Fig. 1D). No basement membrane
labeling was detected with anti-a3(IV) or anti-a4(IV) antibodies,
whereas a linear staining of the epidermal BM was constantly
observed with the anti-aS antibody (Fig. 1E).
Autosomal recessive Alport syndrome (3 kindreds)
Renal tissue. Two types of renal immunolabeling were observed
with the set of antibodies tested.
(1) Normal pattern of distribution of type IV collagen chains
(patient 1, kindred 1). In one case (the female patient with an
identified COL4A4 mutation who developed ESRF at 14 years of
age), no specific change in the immunohistochemical distribution
of type IV collagen chains was detected in the kidney removed
before transplantation. With the anti-a3, a4 and a5(IV) antibod-
ies, linear labeling of the GBM was observed in all preserved and
sclerosing glomeruli (Fig. 2A). It was regular and homogeneous,
but relatively faint compared with the strong labeling of obsoles-
cent glomeruli. Basement membranes of Bowman's capsules and
of distal tubules were normally stained with the anti-a3, a4 and
a5(IV) antibodies. Collecting ducts basement membranes were
stained with anti-a5(IV) antibodies. Anti-[al(IV)2 a2(IV)] and
anti-al(IV) antibodies gave normal mesangial and subendothelial
labeling of patent glomeruli and faint labeling of sclerotic glomer-
uli. Other renal BM were also normally stained.
(2) Abnormal pattern of distribution of type IV collagen chains (3
patients, kindreds 2 and 3), Abnormal distribution of the a3-a5
chains of type IV collagen was observed in two kindreds. It was
similar irs the two male siblings of family 2 and in the female
patient in family 3. With antibodies to the a3(IV) and a4(IV)
chains, no labeling was detected in the GBM of preserved or
scierosing glomeruli, in the Bowman's capsule or in the tubular
basement membrane (Fig. 2B). Sclerotic glomeruli were also
completely negative. Mab A7 (anti-a5(IV) antibody) did not stain
the GBM or the obsolescent glomeruli. In contrast, it labeled
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Fig. 2. Immunofluorescence staining for collagen IV chains of renal specimens of autosomal recessive AS. Normal expression of a3(IV) in patient 1 (A).
No GBM labeling with anti-a3(IV) and -a5(IV) antibodies in patient AA (family 2) (B, C). The capsular and collecting duct BM express the a5(IV)
chain (C, D). Increased GBM expression of the al(IV) chain (2E). Round spots seen on figures B, and D are p-phenylene diamine stained nuclei.
capsular BM, with a segmental or peripheral distribution (Fig.
2C), and the BM of collecting ducts (Fig. 2D).
The al and the a2 chains of type IV collagen, recognized by the
polyclonal anti-[al(IV)2 a2(IV)] and the monoclonal anti-al(IV)
chain antibodies, were distributed not only within the mesangial
matrix but also within the entire thickness of the GBM (Fig. 2E).
They were very faintly expressed in sclerotic glomeruli and
normally expressed in other renal BM.
Skin specimens. In patient 1, normal labeling of the epidermal
BM was observed with the anti-a5(IV) antibody. No patient of
kindreds 2 or 3 underwent a skin biopsy.
Alport syndrome (families 4 to 11)
Renal specimens. The same abnormal pattern of immunohisto-
chemical staining was observed in the eight patients, three males
and five females, belonging to families 4 to 11. It was similar to
that observed in families 2 and 3. The most characteristic features
were the identical distribution of type IV collagen chains in males
and females, the negative labeling of the GBM with the anti-
a3(IV), -a4(IV) and -cs5(IV) antibodies, and the contrast between
the negative labeling of capsular and tubular BM with the
anti-a3(IV) and -a4(IV) antibodies and the positive labeling of
capsular and collecting duct BM with the anti-a5(IV) antibody
(Fig. 3A-C).
Skin specimens. Normal linear labeling of the EBM with the
Mab A7 antibody recognizing the a5(IV) chain was observed in
the three patients studied (1 male and 2 females belonging to
families 5, 7 and 9) (Fig. 3D). The al and a2 chains of type IV
collagen were also normally distributed within skin BM and no
labeling was observed with the anti-a3(IV) and a4(IV) antibodies.
Discussion
The renal immunohistochemical distribution of type IV colla-
gen chains has been studied with a set of monoclonal antibodies
recognizing the al, a3, a4 and aS chains of type IV collagen in
four AS patients affected with the autosomal recessive form of the
disease. Results obtained in eight additional patients highly
suspected to be affected with recessive AS are also presented.
One patient, a girl with a severe autosomal recessive Alport
syndrome due to COL4A4 mutation, has normal renal distribu-
tion of the a3-a5 chains of type IV collagen. In this patient the
distribution of the a5(IV) chain was also found normal in the
epidermal basement membrane. Such normal findings, previously
observed in a minority of X-linked families [41, show that muta-
tions in the autosomal AS genes, as well as mutations in COL4A5
may be associated with incorporation of the defective and the
associated a(IV) chain within the basement membranes. How-
ever, the resulting collageneous network is probably deficient, as
evidenced by the clinical expression of the disorder and the
presence of GBM ultrastructural lesions. In the particular patient
here reported and contrary to the 10 other patients of the present
series who had thick and split GBM, positive GBM staining with
antibodies to the a3-a5 (IV) chains was associated with predom-
inantly thin GBM.
In the three other autosomal recessive AS patients (2 males and
1 female), we found a very unusual pattern of distribution of the
a3-a5 chains of type IV collagen in renal BM. This pattern was
similar in both sexes and characterized by the co-absence of the
a3-a5(IV) chains, in the GBM, and by the dissociation between
the distribution of the a3-a4(IV) and the a5(IV) chains within
extraglomerular BM. No a3-a4(IV) chains could be detected in
capsular and distal TBM whereas the distribution of the a5(IV)
chain was normal in Bowman's capsules and collecting duct BM.
These anomalies are different from those reported in the X-linked
form of the disease in which the a3(IV), a4(IV) and a5(IV)
chains have a discontinuous distribution in females and are
globally absent from the glomerular tuft and the extraglomerular
BM in males [21, 23—25 and personal observation].
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Fig. 3. Immunofluorescence staining for collagen
IV chains of renal and skin BM from patients
with suspected autosomal recessive AS. No GBM
labeling with anti-a3(IV) and -a5(IV)
antibodies (A, B). Positive a5(IV) labeling of
capsular and collecting duct BM (B, C). Normal
labeling of the epidermal BM with the anti-
a5(IV) antibody (D). Round spots seen on A, B
and C are p-phenylene diamine stained nuclei.
In eight additional AS patients, three males and five females,
we observed exactly the same abnormal distribution of the a3(IV),
a4(IV) and a5(IV) chains in renal BM. In addition, in three of
them (1 male and 2 females), the immunohistochemical distribu-
tion of the a5(IV) chain in the EBM could be studied and was
found normal. This combination of normal distribution of the
cs5(IV) chain in the EBM and absence of the a3(IV), a4(IV) and
a5(IV) chains in the GBM contrasts with the absolute concor-
dance observed in X-linked AS between the GBM distribution of
the a3-cá(IV) chains and the EBM distribution of the cs5(IV)
chain [22, 23, 25 and personal experience]. In these eight patients,
the mode of transmission of the disease has not been identified
but clinical and genealogic data are compatible with autosomal
recessive inheritance.
Our immunohistochemical findings are interesting to consider
in regard to the relative renal and skin distribution of the a3(IV)
and c4(IV) chains encoded by the autosomal AS genes COL4A3
and COL4A4, and of the a5(IV) chain encoded by COL4A5, the
gene of X-linked AS. The three chains are usually said to be
associated within the same renal BM [21, 23]. Actually, the three
chains are codistributed within the GBM, but analysis of our
control material clearly shows that a3-a4(IV) on one hand and cs5
(IV) on the other are not exactly codistributed within renal
extraglomerular BM. The a3(IV) and a4(IV) chains are present
in the distal tubule BM and very focally within the Bowman's
capsule, whereas the a5(IV) chain is more extensively expressed
within the Bowman's capsule and is present not only in the distal
tubule BM but also in the collecting duct BM. The same distri-
bution has very recently been reported by Yoshioka et al using a
rat anti-aS monoclonal antibody [25]. Concerning skin BM, it is
well known that the a5(IV) chain only, and not the a3 and a4(IV)
chains, is normally present in the EBM [20, 21, 25].
Complete data concerning the molecular and supramolecular
organization of the different c(IV) chains within the GBM
network of type IV collagen are still lacking but several pieces of
information have been recently obtained [26]. They demonstrate
the existence of crosslinkings between the a3(IV) and the a5(lV)
chains [27], and the a3(IV) and the a4(IV) chains [28], strongly
suggesting that the chains are associated at the molecular and
supramolecular levels. The precise mechanism linking a mutation
in one of the AS a(IV) genes with the failure of stable incorpo-
ration of the other novel chains into AS GBM remains specula-
tive. However, it may be hypothesized that structural changes in
one of the proteins may result in abnormal structure of any type
IV collagen network where the chain is required as a normal
component [9, 26, 29]. This hypothesis can explain that a defect in
any one of the three chains may lead to the absence of all three
chains in the GBM.
Our peculiar findings in autosomal recessive AS are in keeping
with the current knowledge on the organization of the collag-
erieous network and the specific renal and skin distribution of the
novel a(IV) chains. Severe defects in the COL4A3 or COL4A4
genes result in the defective incorporation of the aS protein only
in those BMs (GBM and distal TBM) in which the three proteins
are associated. Conversely, they cannot be expected to induce
changes in the collageneous structure or in the a5(IV) expression
in BM where the a3(IV) and the a4(lV) chains are poorly and
focally expressed (Bowman's capsule) or normally absent (EBM
and collecting duct BM).
The specificity of this peculiar immunohistochemical pattern,
never observed in proven X-linked AS, is not demonstrated since
the autosomal recessive mode of transmission has been proved in
only two kindreds. In the eight other families, the autosomal
recessive inheritance, even if highly suggested by clinical and
genealogic data, has not yet been established. Moreover, no
definitive conclusion may be suggested in the absence of data
regarding the structural organization and the consequences of
structural defects of the recently identified a6(IV) chain [30]. This
reservation is probably just theorical since the gene COL4A6 does
not seem to be an AS gene: it is not experienced in the GBM [31]
and, up to now, no mutation involving only COL4A6 has been
found in AS patients (30, personal experience).
From a practical point of view, the special combination of the
co-absence of the a3(IV), a4(IV) and a5(IV) chains in the GBM,
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and the presence of the a5(IV) chain in a series of extraglomeru-
lar BM including capsular, collecting ducts and epidermal BM
may be considered as a possible useful marker of the autosomal
form of AS.
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